Jump to Content
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Recently viewed
(0)
Save Entry
Searches
(0)
Recently viewed
(0)
Save Search
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Featured Online Content
Supplements
NCCN Meeting Highlights
JNCCN In the News
NCCN News
Highlights of the NCCN Oncology Research Program
Video Roundtables
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Conexiant (FKA Harborside)
Reducing Disparities in Cancer Care
Search
Close
Advanced Search
Help
Volume 20 (2022): Issue 10 (Oct 2022)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
NCCN Clinical Practice Guidelines in Oncology
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
NCCN Guidelines® Insights
NCCN Guidelines® Insights: Survivorship, Version 1.2022
NCCN Guidelines® Insights: Survivorship, Version 1.2022
Oncology Watch
We Are Winning This War!
Commentary
Addressing Racial Inequity in Cancer Care: Self-Awareness Among Oncology Professionals
The Last Word
Enhancing the Design and Evaluation of Care Delivery for Patients on Oral Anticancer Agents
Molecular Insights in Patient Care
Exceptional Response to Erdafitinib in
FGFR2
-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Original Research
Patient, Caregiver, and Oncologist Experiences With and Perceptions of Racial Bias and Discrimination in Cancer Care Delivery
Oral Chemotherapy Metric Performance in Quality Oncology Practice Initiative Practices: Updated Trends and Analysis
Does Clinical Evidence of Heterogeneity Impact Treatment Selection? A Case Study of Abiraterone for Metastatic Prostate Cancer
Relationship Between Longitudinal Coping Strategies and Outcomes in Patients With Acute Myeloid Leukemia
Incident Cardiovascular Diseases Among Survivors of High-Risk Stage II–III Colorectal Cancer: A Cluster-Wide Cohort Study
Immune-Related Adverse Events Among COVID-19–Vaccinated Patients With Cancer Receiving Immune Checkpoint Blockade
Reviews
Diagnosis and Management of Rectal Cancer in Patients Younger Than 50 Years: Rising Global Incidence and Unique Challenges
Optimal Neoadjuvant Strategies for Locally Advanced Rectal Cancer by Risk Assessment and Tumor Location
Correspondence
Letter to the Editor: The Role of Skin Biopsy in the Management of Immune Checkpoint Inhibitor Toxicity
Departments
Highlights of the NCCN Oncology Research Program
NCCN News
Save
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://jnccn.org/view/journals/jnccn/20/10/jnccn.20.issue-10.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Collapse
Expand
Search
Issue
Journal
[18.97.14.83]
18.97.14.83
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
View Expanded
View Table
View Full Size